Outset Medical, Inc. 8-K

What Happened Outset Medical, Inc. (OM) filed an 8-K on June 5, 2026 reporting the results of its virtual Annual Meeting held June 4, 2026 (record date April 9, 2026). Of 18,529,233 shares outstanding and entitled to vote, 13,890,864 shares were present virtually or by proxy, establishing a quorum. Stockholders elected Brent D. Lang and Karen Prange as Class III directors (terms until the 2029 annual meeting), approved the company’s 2025 named executive officer compensation on an advisory basis, and ratified KPMG LLP as the independent registered public accounting firm for fiscal 2026.

Key Details

• Record date and shares outstanding: 18,529,233 shares (April 9, 2026); shares present at meeting: 13,890,864.
• Director elections:
  • Brent D. Lang — For: 8,109,357; Withheld: 2,642,698; Broker Non-Votes: 3,138,809.
  • Karen Prange — For: 10,317,822; Withheld: 434,233; Broker Non-Votes: 3,138,809.
• Advisory vote on executive compensation (non-binding): For 7,548,774; Against 3,196,870; Abstain 6,411; Broker Non-Votes 3,138,809.
• Auditor ratification: KPMG LLP ratified — For 13,554,287; Against 20,047; Abstain 316,530.

Why It Matters The meeting results confirm the company’s board composition through 2029 with the election of two Class III directors and maintain continuity in financial oversight by ratifying KPMG as auditor for 2026. The advisory “say-on-pay” proposal was approved but drew notable opposition (about 30% of votes cast against), which is relevant for investor governance and management accountability discussions. Broker non-votes on the director and say-on-pay items indicate shares held by brokers that did not vote on these non-routine matters, which can affect vote margins.